Musashi Europe’s Research Allowance success powered by innoscripta’s software platform

Meet Musashi Europe

Musashi Europe has been an international supplier to the automotive industry for more than nine decades. One of the market leaders in forging and machining, they operate widely with more than 2,500 employees in Europe alone.

As a member of Musashi Seimitsu Industry Group, Musashi Europe focuses on the production of components for use in drive and chassis technology. Their successful journey is rooted in consistent focus on customer requirements and offering suitable solutions through their global presence.

The Challenge

“We had contact with various providers, but innoscripta stood out. Applying for the research allowance is not a simple process, and Musashi had little prior experience in this area.”

Major challenges Musashi Europe faced prior to their collaboration with innoscripta include:

• Complexity of the research allowance: Understanding the concept of the research allowance, its eligibility criteria, and prerequisites needed to proceed with the application is a multi-dimensional task. For a company focusing on core R&D projects, the hurdle lies in comprehending the entire research allowance programme and finding a way to capitalise on the opportunity.

• Preparations to claim the research allowance: Drafting an effective application for the research allowance consists of various steps that need to be carefully completed. The concise and transparent project documentation with no data omitted and accurate qualified costs calculations with traceable evidence are two of the significant elements.

The Solution

• Employing innoscripta’s software platform: “We can prepare the documentation for the research allowance in Excel as well, but all necessary data is stored in the IMS and documented in a tamper-proof way.”

The problems Musashi Europe faced in terms of documenting the R&D activities and precise cost calculations were made easy and streamlined using innoscripta’s software platform.

• Drafting applications: innoscripta extended their support to Musashi Europe in efficiently drafting the applications for BSFZ approval. This includes crafting an error-free project description that highlights the R&D nature of the project, which plays a key role in earning a positive response from concerned authorities. In addition, innoscripta created audit-proof documentation in order to submit the application to the tax office in a second step.

The Impact

The collaboration with innoscripta resulted in obtaining successful outcomes for Musashi Europe.

• Excellent project documentation: Using innoscripta’s software platform all the elements of the R&D project including the project information, details of R&D personnel, cost calculations and the supporting evidence were documented in one place. The software platform also enables a seamless internal collaboration among the responsible stakeholders in the research project.

• Approved research allowance: The ultimate advantage Musashi Europe generated by collaborating with innoscripta was the ‘research allowance’. The guidance from innoscripta, effective project documentation, and high-quality applications led to a positive result of securing the financial support for the R&D project.

Conclusion

Musashi Europe appreciates the support and family-like environment innoscripta offered, and highlights the excitement to continue this successful collaboration in the future.

“If any questions arise during the application process, we know there’s always a contact person available at innoscripta. This gives us more time to do what we love: developing groundbreaking technologies.”